Occult cancer of the fallopian tube in BRCA-1 germline mutation carriers at prophylactic oophorectomy: a case for recommending hysterectomy at surgical prophylaxis

Gynecol Oncol. 2001 Feb;80(2):176-80. doi: 10.1006/gyno.2000.6071.

Abstract

Objective: BRCA-1 and BRCA-2 germline mutations increase the risk of ovarian and breast cancer. Primary cancer of the fallopian tube is rare; however, recent evidence suggests that patients harboring a germline mutation conferring an increased risk of ovarian cancer may be at risk for fallopian tube cancer as well. We discuss the finding of occult fallopian tube cancer diagnosed at surgical prophylaxis in women harboring BRCA-1 mutations.

Methods/results: Two patients undergoing surgical prophylaxis to address an increase in ovarian cancer risk were discovered to harbor occult primary fallopian tube carcinoma on final pathology review. Mutational analysis confirmed the presence of a deleterious mutation in BRCA-1 in both patients.

Conclusion: Currently, consensus opinions regarding ovarian cancer surgical prophylaxis in gene mutation carriers do not include hysterectomy as part of the preventative procedure. This report as well as a growing number of cases of fallopian tube cancer reported in known BRCA-1 and BRCA-2 mutation carriers has important implications for recommendations regarding surgical prophylaxis in these women.

Publication types

  • Case Reports
  • Research Support, U.S. Gov't, P.H.S.

MeSH terms

  • BRCA2 Protein
  • Fallopian Tube Neoplasms / genetics*
  • Fallopian Tube Neoplasms / surgery
  • Female
  • Genes, BRCA1 / genetics*
  • Genetic Predisposition to Disease
  • Germ-Line Mutation*
  • Humans
  • Hysterectomy*
  • Middle Aged
  • Neoplasm Proteins / genetics
  • Ovarian Neoplasms / genetics
  • Ovarian Neoplasms / prevention & control*
  • Ovarian Neoplasms / surgery
  • Ovariectomy*
  • Pedigree
  • Transcription Factors / genetics

Substances

  • BRCA2 Protein
  • Neoplasm Proteins
  • Transcription Factors